Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations


38.01   0.94 (2.54%) 05-20 16:02
Open: 38.36 Pre. Close: 0
High: 0 Low: 0
Volume: 687,706 Market Cap: 8627M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 38.403 - 38.556 38.556 - 38.687
Low: 37.573 - 37.764 37.764 - 37.928
Close: 37.676 - 37.982 37.982 - 38.246

Technical analysis

as of: 2019-05-20 4:29:50 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 45.25     One year: 47.51
Support: Support1: 35.61    Support2: 29.63
Resistance: Resistance1: 38.74    Resistance2: 40.68
Pivot: 37.50
Moving Average: MA(5): 37.29     MA(20): 37.81
MA(100): 38.12     MA(250): 37.11
MACD: MACD(12,26): -0.61     Signal(9): -0.68
Stochastic oscillator: %K(14,3): 53.59     %D(3): 47.59
RSI: RSI(14): 49.51
52-week: High: 41.55  Low: 32.33  Change(%): 6.3
Average Vol(K): 3-Month: 124752  10-Days: 142872

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
QGEN has closed below upper band by 38.0%. Bollinger Bands are 49.1% wider than normal. The large width of the bands suggest high volatility as compared to QGEN's normal range. The bands have been in this wide range for 6 bars. This is a sign that the current trend might continue.

Headline News

Mon, 20 May 2019 13:46:36 Z
Health Care Sector Update for 05/20/2019: MDCO, QGEN, INNT, JNJ, PFE, ABT, MRK, AMGN

Fri, 17 May 2019 18:12:37 Z
QIAGEN Partners Inovio to Develop Companion Diagnostics

Mon, 13 May 2019 20:09:46 Z
Qiagen Looks to Growth in the Second Half of the Year

Mon, 13 May 2019 16:07:51 Z
Qiagen is Now Oversold (QGEN)

Wed, 08 May 2019 02:13:55 Z
Qiagen NV (QGEN) Q1 2019 Earnings Call Transcript

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Diagnostics Research
Shares Out. (M) 226.97
Shares Float (M) 226.97
% Held by Insiders
% Held by Institutions 98.90
Shares Short (K) 3404
Shares Short P. Month (K)

Stock Financials

EPS 1.340
EPS Est. Current Year 1.180
EPS Est. Next Year 1.320
EPS Est. Next Quarter 0.420
Forward EPS 1.500
Book Value (p.s.) 3.230
PEG Ratio 2.34
Profit Margin 12.53
Operating Margin 18.84
Return on Assets (ttm) 4.0
Return on Equity (ttm) 8.0
Qtrly Rev. Growth 1.5
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.)
Qtrly Earnings Growth -8.60
Operating Cash Flow (M) 356.02
Levered Free Cash Flow (M) 244.09

Stock Valuations

P/E 28.36
P/E Growth Ratio 0.03
P/BV 11.76
P/S 1295024000.00
P/CF 24.23

Dividends & Splits

Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2017-01-25
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.